Trexgen Pharmaceuticals Pvt. Ltd.
completes it first financial year with success with coverage of all major territories in Gujarat through its highly skilled & trained team of medical professionals. It ventures into new areas of therapy, predominantly Neuropathy & Hyperhomocysteinemia with launching of products with novel drug delivery system like Bi-layered tablet technology.
To cater the highly quality oriented pediatric segment, it launches its flagship brand, Trexclav (228.5/457) with glass bottle & sterile water for reconstitution, making it among the very few brands in the market that provides the aforementioned glass bottle packaging for better stability and launches Trexora-R, a highly economical combination of Probiotics for acute watery diarrhea in pediatric patients. With a strong new product pipeline and a projected launch of innovative products for management of Osteoporosis, Polycystic Ovary Syndrome (PCOS) & its plans to launch a new injectable division shortly, it will be an exciting year for the company.
Trexgen Pharmaceuticals Pvt. Ltd. launches new products, thus expanding its Ortho, Paediatric & Gynec Portfolio. The launch of this new products will expand its targeted therapies and make a strong presence in the speciality segment, allowing it to compete with leading brands.
Trexgen Pharmaceuticals Pvt. Ltd. launches its operations in the state of Gujarat with a wide range products covering various therapeutic segments. With a highly dedicated and professional team, the company aims to provide quality pharmaceuticals products and build relationships with its customers. The company aims to become a leader in marketing innovative formulations for rapidly increasing healthcare problems.